• Title of article

    Personalized Medicine: Pharmacogenomics and Drug Development

  • Author/Authors

    Mirsadeghi، Somayeh نويسنده Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. Mirsadeghi, Somayeh , Larijani، Bagher نويسنده ,

  • Issue Information
    ماهنامه با شماره پیاپی 0 سال 2017
  • Pages
    16
  • From page
    150
  • To page
    165
  • Abstract

    Personalized medicine aims is to supply the proper drug to the proper patient within the right dose. Pharmacogenomics (PGx) is to recognize genetic variants that may influence drug efficacy and toxicity. All things considered, the fields cover a wide area, including basic drug discovery researches, the genetic origin of pharmacokinetics and pharmacodynamics, novel drug improvement, patient genetic assessment and clinical patient administration. At last, the objective of Pharmacogenomics is to anticipate a patient’s genetic response to a particular drug as a way of presenting the best possible medical treatment. By predicting the drug response of an individual, it will be possible to increase the success of therapies and decrease the incidence of adverse side effect.

  • Journal title
    Acta Medica Iranica
  • Serial Year
    2017
  • Journal title
    Acta Medica Iranica
  • Record number

    2404564